Dow Jones Reverses Lower On Weak Data; Oil Prices Rally On Surprise Production Cut | Investor's Business Daily – Investor's Business Daily

BREAKING: Market Falls Sharply With Fed Meeting On Tap

The Dow Jones Industrial Average reversed lower Tuesday morning after the release of key economic data, as U.S oil prices rose after a surprise OPEC+ production cut.
IBD 50 stock Shockwave Medical (SWAV) dropped more than 6% after an Oppenheimer downgrade. Electric-vehicle leader Tesla (TSLA) rose almost 1% Tuesday. Among the Dow Jones industrials, tech titans Apple (AAPL) and Microsoft (MSFT) were both higher after today’s stock market open.
In the market’s current volatility, Arista Networks (ANET), Costco (COST) and Ulta Beauty (ULTA) — as well as Dow Jones stock Chevron (CVX) — are among the top issues to buy and watch. Keep in mind the market’s increased volatility is a good reason for investors to be more defensive.
Costco is an IBD Leaderboard stock in the wake of a recent breakout, while Chevron and Ulta Beauty were featured in last week’s Stocks Near A Buy Zone column.
After the opening bell Tuesday, the Dow Jones Industrial Average turned down 0.7%, while the S&P 500 fell 0.8%. And the tech-heavy Nasdaq composite lost 1.1% in morning trade.
Among exchange-traded funds, the Nasdaq 100 tracker Invesco QQQ Trust (QQQ) fell 0.4% and the SPDR S&P 500 ETF (SPY) moved down 0.2% in early trade.
The 10-year Treasury yield ticked higher to 3.28% early Tuesday, recovering from Friday’s losses. Last week, the 10-year Treasury yield notched its highest closing level since June 21.
U.S. oil prices slashed gains Tuesday, threatening to add to last week’s sharp losses. West Texas Intermediate futures rallied 4% Monday morning after OPEC+ — which includes the Organization of the Petroleum Exporting Countries and key allies such as Russia —  agreed to cut production quotas by 100,000 barrels per day, starting in October. But WTI futures erased early gains, trading back around $87 a barrel.
Early Tuesday, the U.S. Services Purchasing Managers’ Index, known as Services PMI, measured 43.7, below Econoday estimates that called for a 44.1 reading. It was its lowest reading since May 2020. August survey data signaled a sharp decline in business activity across the U.S. service sector.
Next, the Institute For Supply Management services index reading measured 56.9, topping the 55.4 estimate.
Nasdaq Extends Losing Streak; iPhone 14 On Call
The stock market ended lower Friday, with the Nasdaq composite once again the worst performer out of the major indexes. It extended its losing streak to six sessions as it fell 1.3%.
Friday’s The Big Picture column commented, “The S&P 500 ended near session lows as it skidded 1.1%. It was turned away at its 50-day line following an early pop. It has now fallen in five of the past six trading days.”
If you’re new to IBD, consider taking a look at its stock trading system and CAN SLIM basics. Recognizing chart patterns is one key to the investment guidelines. IBD offers a broad range of growth stock lists, such as Leaderboard and SwingTrader.
Investors also can create watchlists, find companies nearing a buy point, or develop custom screens at IBD MarketSmith.
Five Dow Jones Stocks To Watch Now
Dow Jones stock Chevron rallied 1.5% Friday, snapping a three-day losing streak. Shares continue to build a cup base with a 182.50 buy point — according to IBD MarketSmith chart analysis — amid a strong performance by energy stocks so far this year. An early entry at 164.76 is also in play. The stock rose 1.2% early Tuesday, as oil prices moved higher.
CVX stock shows a strong 97 out of a perfect 99 IBD Composite Rating, per the IBD Stock Checkup. Investors can use the IBD Composite Rating to easily gauge the quality of a stock’s fundamental and technical metrics.
4 Top Growth Stocks To Buy And Watch In The Current Stock Market Rally
Arista Networks has added a handle to a double-bottom base, placing the correct entry at 132.97, according to IBD MarketSmith chart analysis. Arista’s relative strength line is starting to give ground, as the stock falls below its long-term 200-day line. ANET shares were up 0.9% early Tuesday.
IBD Leaderboard stock Costco gave up much-needed support at its 50-day line Friday and is falling further below its 552.81 buy point from a cup with handle. The stock is close to triggering the 7%-8% loss-cutting sell rule. Shares traded up 0.6% Tuesday.
Cosmetics retailer Ulta Beauty remains modestly above a 417.08 buy point in a double bottom base following Friday’s 0.3% drop. ULTA shares were up 0.5% Tuesday morning.
Join IBD experts as they analyze leading stocks in the current stock market rally on IBD Live
Tesla stock skidded 2.5% Friday, closing right at its 50-day line, which is a potential support level to watch. Shares of the electric-vehicle giant gained almost 1% Tuesday morning, as Wolfe Research upgraded the stock from peer perform to outperform, with a 360 price target.
Tesla stock found resistance at its 200-day line in recent months and is about 35% off its 52-week high.
Among Dow Jones stocks, Apple shares declined 1.4% Friday, closing below support at their 50-day line. The stock is about 12% away from a buy point at 176.25 off a cup with handle. Despite the recent losses, the stock’s relative strength line is holding near new highs, indicating steady stock market outperformance. Shares rose 0.65% Tuesday morning.
Microsoft fell 1.7% Friday, extending a losing streak to six sessions and falling further below its 50-day line. Shares remain sharply below their long-term 200-day line and about 27% off their 52-week high. The stock gained 0.4% early Tuesday.
Be sure to follow Scott Lehtonen on Twitter at @IBD_SLehtonen for more on growth stocks and the Dow Jones Industrial Average.
Top Growth Stocks To Buy And Watch
Learn How To Time The Market With IBD’s ETF Market Strategy
Find The Best Long-Term Investments With IBD Long-Term Leaders
MarketSmith: Research, Charts, Data And Coaching All In One Place
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
2:47 PM ET All eyes are on the Fed meeting, but the stock market has already sold off hard as it rate hike…
2:47 PM ET All eyes are on the Fed meeting, but the stock…
Biotechs are making remarkable strides in clinical testing, and biotech stocks are outperforming the rest of the market. (© Chris Gash)
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD’s investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2022 Investor’s Business Daily, LLC. All rights reserved